125 related articles for article (PubMed ID: 33625080)
1. Successful High-dose Chemotherapy in Combination With Autologous Peripheral Blood Stem Cell Transplantation in an Anuric Child With Neuroblastoma.
Inoguchi T; Hamada R; Kubota W; Terano C; Harada R; Honda M; Yamaoka S; Yokokawa Y; Yuza Y; Hataya H
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1156-e1158. PubMed ID: 33625080
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
3. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.
Yi ES; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
Pediatr Blood Cancer; 2020 Feb; 67(2):e28066. PubMed ID: 31736249
[TBL] [Abstract][Full Text] [Related]
5. Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.
Kato S; Kubota Y; Watanabe K; Hogetsu K; Arakawa Y; Koh K; Takita J; Hiwatari M
Pediatr Transplant; 2020 Nov; 24(7):e13772. PubMed ID: 32543778
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
[TBL] [Abstract][Full Text] [Related]
7. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma.
Sunami K; Shinagawa K; Sawamura M; Sakai A; Saburi Y; Imamura Y; Mizuno I; Tamaki S; Kamimura T; Tsuda H; Gondo H; Hino N; Shimazaki C; Miyata A; Tajima F; Takemoto Y; Miwa A; Chou T; Harada M
Int J Hematol; 2009 Dec; 90(5):635-642. PubMed ID: 19936876
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
Choi YB; Bae GE; Lee NH; Kim JS; Lee SH; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2015 Aug; 30(8):1062-7. PubMed ID: 26240483
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases.
Tsuchiyama J; Imajo K; Yoshino T; Nanba N; Toyota A; Yoshida C; Fujii K; Kondo E; Okazuka K; Hashimoto S; Toba K; Fuse I; Aizawa Y; Harada M; Tsubota T
Ann Hematol; 2002 Oct; 81(10):588-92. PubMed ID: 12424541
[TBL] [Abstract][Full Text] [Related]
11. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Endo M; Tanosaki R
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807
[TBL] [Abstract][Full Text] [Related]
12. Analysis of pediatric autologous PBSC apheresis and transplant: age is a major factor affecting post-transplant toxicity.
Dubrovsky L; McCarter RJ; Fry TJ; Wong E; Cheng Y; Perez-Albuerne ED
Pediatr Blood Cancer; 2012 Aug; 59(2):301-5. PubMed ID: 22180259
[TBL] [Abstract][Full Text] [Related]
13. Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer.
Ikeba K; Okubo M; Takeda S; Kinoshita K; Maeda H
Int J Clin Oncol; 2004 Apr; 9(2):113-9. PubMed ID: 15108043
[TBL] [Abstract][Full Text] [Related]
14. Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.
Sung KW; Yoo KH; Chung EH; Cho EJ; Jung HL; Koo HH; Lee SK; Lim DH; Kim DY; Kim DW; Kim HR; Kim SW
J Korean Med Sci; 2002 Aug; 17(4):537-43. PubMed ID: 12172052
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.
Suh JM; Yoo KH; Sung KW; Kim JY; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
J Korean Med Sci; 2009 Aug; 24(4):660-7. PubMed ID: 19654949
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
Murayama T; Fukuda T; Okumura H; Sunami K; Sawazaki A; Maeda Y; Tsurumi H; Uike N; Hidaka T; Takatsuka Y; Eto T; Tsuda H; Fujisaki T; Miyamoto T; Tsuneyoshi N; Iyama S; Nagafuji K; Harada M
Int J Hematol; 2016 Jun; 103(6):676-85. PubMed ID: 27084252
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas.
Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
Pediatr Transplant; 2018 May; 22(3):e13127. PubMed ID: 29453811
[TBL] [Abstract][Full Text] [Related]
18. Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
Seo ES; Shin M; Lim H; Cho HW; Ju HY; Cho YS; Yoo KH; Koo HH; Lee JW; Sung KW
Pediatr Blood Cancer; 2022 Jul; 69(7):e29502. PubMed ID: 34889513
[TBL] [Abstract][Full Text] [Related]
19. [Early relapse after autologous peripheral blood stem cell transplantation in an elderly patient with enteropathy-associated T-cell lymphoma].
Sumii Y; Yamamoto K; Omura Y; Oda W; Kondo E; Oyama T; Kamoi C; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Imajo K
Rinsho Ketsueki; 2018; 59(7):889-894. PubMed ID: 30078799
[TBL] [Abstract][Full Text] [Related]
20. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant.
Hillier K; Cheng WS; Whittle SB; Krance R; Foster JH
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e569-e574. PubMed ID: 32032244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
